Pages that link to "Q3271540"
Jump to navigation
Jump to search
The following pages link to mechanism of action (Q3271540):
Displaying 50 items.
- antioxidant (Q133948) (← links)
- antacid (Q274083) (← links)
- Endothelin receptor antagonist (Q390709) (← links)
- enzyme activator (Q422816) (← links)
- antifoaming agent (Q904035) (← links)
- peptidomimetic (Q2069797) (← links)
- aversive agent (Q4828343) (← links)
- CCR5 receptor antagonist (Q5009692) (← links)
- druggability (Q5308937) (← links)
- mode of action (Q6888113) (← links)
- radiopharmaceutical (Q9178218) (← links)
- alkylating agent (Q17172594) (← links)
- Serotonin and depression: a disconnect between the advertisements and the scientific literature (Q21090148) (← links)
- The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis (Q21090577) (← links)
- Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis (Q21143851) (← links)
- Giving legs to restless legs: a case study of how the media helps make people sick (Q21144708) (← links)
- The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease (Q21146748) (← links)
- New treatment options against gram-negative organisms (Q21194906) (← links)
- Phosphodiesterase 4-targeted treatments for autoimmune diseases (Q21245284) (← links)
- Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis (Q21254640) (← links)
- Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials (Q21261910) (← links)
- EDTA chelation therapy for cardiovascular disease: a systematic review (Q21261944) (← links)
- Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis (Q21999458) (← links)
- Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis (Q21999508) (← links)
- Economic considerations in the management of Alzheimer's disease (Q22241448) (← links)
- Chelation in metal intoxication (Q22305611) (← links)
- The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary disease (Q22305858) (← links)
- Goitrogenic and estrogenic activity of soy isoflavones (Q24529917) (← links)
- Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins (Q24537103) (← links)
- N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities (Q24568289) (← links)
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis (Q24595703) (← links)
- Safety and efficacy of azacitidine in myelodysplastic syndromes (Q24596561) (← links)
- Advances in understanding and treating ADHD (Q24601949) (← links)
- A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics (Q24602122) (← links)
- Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP? (Q24602803) (← links)
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors (Q24602845) (← links)
- A review of obsessive-compulsive disorder in children and adolescents (Q24604879) (← links)
- Bioactive peptides from muscle sources: meat and fish (Q24610066) (← links)
- Differential clinical profile of candesartan compared to other angiotensin receptor blockers (Q24613321) (← links)
- Clinical and experimental applications of sodium phenylbutyrate (Q24613511) (← links)
- Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation (Q24615052) (← links)
- Update of the human and mouse SERPIN gene superfamily (Q24622280) (← links)
- Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis (Q24627908) (← links)
- Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis (Q24628826) (← links)
- Tricyclic antidepressants and headaches: systematic review and meta-analysis (Q24629493) (← links)
- Ezetimibe therapy: mechanism of action and clinical update (Q24630302) (← links)
- Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials (Q24632223) (← links)
- Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials (Q24632255) (← links)
- The emerging use of aromatase inhibitors for endometriosis treatment (Q24633555) (← links)
- Carvedilol in hypertension treatment (Q24642654) (← links)